575 related articles for article (PubMed ID: 23675778)
1. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.
Medvedev AE
J Interferon Cytokine Res; 2013 Sep; 33(9):467-84. PubMed ID: 23675778
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. CD14 and toll-like receptors: potential contribution of genetic factors and mechanisms to inflammation and allergy.
Leung TF; Tang NL; Wong GW; Fok TF
Curr Drug Targets Inflamm Allergy; 2005 Apr; 4(2):169-75. PubMed ID: 15853738
[TBL] [Abstract][Full Text] [Related]
4. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.
Fleer A; Krediet TG
Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor polymorphism in host immune response to infectious diseases: A review.
Mukherjee S; Huda S; Sinha Babu SP
Scand J Immunol; 2019 Jul; 90(1):e12771. PubMed ID: 31054156
[TBL] [Abstract][Full Text] [Related]
6. Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer.
Trejo-de la O A; Hernández-Sancén P; Maldonado-Bernal C
Genes Immun; 2014 Apr; 15(4):199-209. PubMed ID: 24622688
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in Toll-like receptors and disease susceptibility.
Netea MG; Wijmenga C; O'Neill LA
Nat Immunol; 2012 May; 13(6):535-42. PubMed ID: 22610250
[TBL] [Abstract][Full Text] [Related]
9. Important aspects of Toll-like receptors, ligands and their signaling pathways.
Chang ZL
Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease.
Schröder NW; Schumann RR
Lancet Infect Dis; 2005 Mar; 5(3):156-64. PubMed ID: 15766650
[TBL] [Abstract][Full Text] [Related]
11. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.
Kawai T; Akira S
Nat Immunol; 2010 May; 11(5):373-84. PubMed ID: 20404851
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future.
Vijay K
Int Immunopharmacol; 2018 Jun; 59():391-412. PubMed ID: 29730580
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in toll-like receptor pathway genes influence asthma and atopy.
Tesse R; Pandey RC; Kabesch M
Allergy; 2011 Mar; 66(3):307-16. PubMed ID: 21039600
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases.
Skevaki C; Pararas M; Kostelidou K; Tsakris A; Routsias JG
Clin Exp Immunol; 2015 May; 180(2):165-77. PubMed ID: 25560985
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility.
Sameer AS; Nissar S
Biomed Res Int; 2021; 2021():1157023. PubMed ID: 34552981
[TBL] [Abstract][Full Text] [Related]
16. Insights into the toll-like receptors in sexually transmitted infections.
Yadav S; Verma V; Singh Dhanda R; Yadav M
Scand J Immunol; 2021 Jan; 93(1):e12954. PubMed ID: 32762084
[TBL] [Abstract][Full Text] [Related]
17. [Innate immunity: structure and function of TLRs].
Delneste Y; Beauvillain C; Jeannin P
Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
[TBL] [Abstract][Full Text] [Related]
18. Manifold mechanisms of Toll-like receptor-ligand recognition.
Ishii KJ; Coban C; Akira S
J Clin Immunol; 2005 Nov; 25(6):511-21. PubMed ID: 16380815
[TBL] [Abstract][Full Text] [Related]
19. Porcine Toll-like receptors: the front line of pathogen monitoring and possible implications for disease resistance.
Uenishi H; Shinkai H
Dev Comp Immunol; 2009 Mar; 33(3):353-61. PubMed ID: 18590761
[TBL] [Abstract][Full Text] [Related]
20. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
